Vilanterol
Back to searchMolecule Structure
Scientific Name
Vilanterol
Description of the Drug
Vilanterol is a long-acting beta2-adrenergic agonist used in combination with other bronchodilators for the management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09082
http://www.drugbank.ca/drugs/DB09082
Brand Name(s)
Not Available
Company Owner(s)
Glaxo Group Ltd England Dba Glaxosmithkline, Glaxosmithkline Intellectual Property Development Ltd England
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL142630 | |
| DrugBank | DB09082 | |
| PubChem: Thomson Pharma | 15180153 | |
| PubChem | 10184665 | |
| Nikkaji | J3.221.142I | |
| BindingDB | 50416060 | |
| EPA CompTox Dashboard | DTXSID80198318 | |
| DrugCentral | 4799 | |
| ChemicalBook | CB22542797 | |
| Guide to Pharmacology | 7353 | |
| rxnorm | VILANTEROL | VILANTEROL TRIFENATATE |
| ChEBI | 75037 | |
| ZINC | ZINC000003991624 |
